logo
  1. Home
  2. Stocks
  3. Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals Share Price

Small Cap | Pharmaceuticals and health care | BSE: 524572

₹69.99 image-0.26 (-0.37 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 71.66

High (₹) 71.66

Low (₹) 67.00

Prev. Close (₹) 70.25

Volume 10,439

VWAP (₹) 68.24

ROCE (%) -17.61

Industry P/E 43.95

TTM P/E -20.00

P/B Ratio 3.50

Market Cap (₹) Cr.246.84

Dividend Yield (%)--

EPS (₹) -3.56

ROE-17.81%

Sales Growth (%) --

Profit Growth (%)56.74

Day Range

71.6671.66

L
H

52 Week Range

31.9087.46

L
H

Historical Returns

Returns (6M)

66.76 %

Returns (1Y)

31.39 %

Returns (3Y)

412.75 %

Returns (5Y)

1316.8 %

Returns (6M)

66.76 %

Returns (1Y)

31.39 %

Returns (3Y)

412.75 %

Returns (5Y)

1316.8 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Increasing Revenue every Quarter for the past 4 Quarters
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Positive ROC (9) indicates upward momentum.
  • Price above the pivot point indicates bullish sentiment.
  • Price above EMA and SMA (50) indicates bullish momentum.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 48.53

MFI 25.68

ATR 5.06

Commodity Channel Index 8.24

ROC125 56.49

ROC21 0.59

Williams %R -41.05

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current71.6174.4976.9969.1166.2363.7360.85
Week Ago67.1367.1367.1367.1367.1367.1367.13
Month Ago71.7072.3073.0570.9570.3569.6069.00

EMA & SMA
info_icon

69.99

Current Price

EMA & SMApin

Bullish Moving Averages

20

Bearish Moving Averages

0

5 Day 68.88

9 Day 65.24

10 Day 65.59

12 Day 66.59

14 Day 67.37

20 Day 68.49

26 Day 69.08

50 Day 69.47

100 Day 62.55

200 Day 55.04

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
TOPGAIN FINANCE PRIVATE LIMITEDbulkBuy19 Dec, 2022₹32.4280,000BSE
EPITOME TRADING AND INVESTMENTSbulkBuy19 Dec, 2022₹32.4575,000BSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkSell15 Dec, 2022₹29.2894,011BSE
TOPGAIN FINANCE PRIVATE LIMITEDbulkBuy15 Dec, 2022₹28.0552,000BSE
EPITOME TRADING AND INVESTMENTSbulkBuy15 Dec, 2022₹29.3360,456BSE
BP EQUITIES PVT. LTD.bulkSell14 Dec, 2022₹29.4957,806BSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkBuy14 Dec, 2022₹28.9394,011BSE
EPITOME TRADING AND INVESTMENTSbulkBuy14 Dec, 2022₹29.291,00,000BSE
BP EQUITIES PVT. LTD.bulkBuy14 Dec, 2022₹29.5012BSE
RAVI KUMAR KROVVIDIbulkSell26 Jul, 2022₹12.101,50,000BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
01 Jan, 2025MALIEMADOM RAMASWAMY IYER MAHADEVANDisposal₹61.4920,978BSE
31 Dec, 2024Shreedhara ShettyDisposal₹63.941,28,071BSE
26 Dec, 2024Shreedhara ShettyDisposal₹60.9076,800BSE
23 Dec, 2024Dr. Shankarappa Nagaraja Vinaya BabuAcquisition₹25.0018,20,854BSE
20 Dec, 2024Shreedhara ShettyDisposal₹58.4723,813BSE
17 Dec, 2024Shreedhara ShettyDisposal₹59.208,204BSE
16 Dec, 2024Shreedhara ShettyDisposal₹60.7519,353BSE
12 Dec, 2024Shreedhara ShettyDisposal₹58.5136,268BSE
12 Dec, 2024Shreedhara ShettyDisposal₹55.2629,229BSE
11 Dec, 2024Shreedhara ShettyDisposal₹53.1137,973BSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
19 Feb, 2025BSE IndiaPostal Ballot notice dated February 12, 2025.
13 Feb, 2025BSE IndiaDisclosure under regulation 30 of SEBI (LODR), regulation 2015 - Intimation on loan agreement.
12 Feb, 2025BSE IndiaIntimation of alteration in capital clause of the Memorandum of Association of the Company, subject to approval of shareholders of the Company
12 Feb, 2025BSE IndiaThis is to inform you that Board of Directors in their meeting held today i.e. February 12, 2025 considered and approved the re-appointment of Mr.Venu Madhava Kaparthy (DIN: 00021699) as Whole Time Director designated as Executive Director of the Company and Ms.Mini Manikantan (DIN: 09663184) as Whole Time Director designated as Executive Director of the Company Subject to approval of the members of the Company.
12 Feb, 2025BSE IndiaIntegrated filing (financials) for the quarter and nine months ended December 31, 2024.
12 Feb, 2025BSE IndiaFinancial results for the Quarter and Nine Months ended December 31, 2024
12 Feb, 2025BSE IndiaUnaudited Financial Results For The Quarter And Nine Months Ended 31st December 2024
07 Feb, 2025BSE IndiaPHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve the unaudited Financial results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2024.
06 Feb, 2025BSE IndiaIn terms of Regulation 30, this is to inform you that the Board of Directors of the Company has approved and passed resolution by circulation on February 06, 2025 for acquisition (Purchase) of Industrial Land Plots.\r\nDetails are attached.
05 Feb, 2025BSE IndiaThis is in furtherance to our previous intimations regarding investment and update on the same in Anugraha Chemicals (\Firm\). Details as required under SEBI Listing Regulations, 2015 disclosure circular has been attached.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--10 Feb, 202512 Feb, 2025
Quarterly Results--08 Nov, 202413 Nov, 2024
Audited Results--22 May, 202428 May, 2024
Quarterly Results--05 Feb, 202412 Feb, 2024
Preferential issue of shares--04 Jan, 202406 Jan, 2024
Quarterly Results--07 Nov, 202311 Nov, 2023
Quarterly Results--31 Jul, 202304 Aug, 2023
Audited Results--24 May, 202329 May, 2023
Quarterly Results--06 Feb, 202313 Feb, 2023
Others--13 Jan, 202317 Jan, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Apr, 2024Mar, 2024Dec, 2023

About Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals is a Public Limited Listed company incorporated on 01/03/1989 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L52520KA1989PLC173979 and registration number is 173979. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 0.03 Cr. and Equity Capital is Rs. 35.27 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1989

Managing Director

-- --

NSE Symbol

--

Pharmaids Pharmaceuticals Management

NameDesignation
Dr. Shankarappa Nagaraja Vinaya BabuChairman, Non Ind & Non Exe Director
Mr. Venu Madhava KaparthyExecutive Director
Ms. Mini ManikantanExecutive Director
Mr. Shreedhara ShettyNon Exe.Non Ind.Director
Mr. Methuku NageshIndependent Director
Mr. P N VijayIndependent Director
Mr. Mopperthy SudheerIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)		₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)		₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)		₹1,093.000 - ₹1,420.200

FAQs on Pharmaids Pharmaceuticals

What is the share price of Pharmaids Pharmaceuticals?

The share price of Pharmaids Pharmaceuticals on 13 Mar, 2025 is ₹ 69.99.

What is 52W high and 52W low share price of Pharmaids Pharmaceuticals?

The highest and lowest 52W share prices of Pharmaids Pharmaceuticals are ₹ 87.460 and ₹ 31.900

What is the market cap of Pharmaids Pharmaceuticals?

The market capitalization of Pharmaids Pharmaceuticals as of 13 Mar, 2025 is ₹ 246.84 Crores

What is the P/E ratio of Pharmaids Pharmaceuticals?

The current P/E ratio of Pharmaids Pharmaceuticals as of 13 Mar, 2025 is 43.95

What is the PB ratio of Pharmaids Pharmaceuticals?

The PB ratio of Pharmaids Pharmaceuticals as of 13 Mar, 2025 is 3.50

Top Gainers

PASUSPG

Pasupati Spinning & Weaving Mills

₹41.02image

₹34.29 (0.20%)

OONE

ObjectOne Information Systems

₹8.84image

₹7.37 (0.20%)

JAINCO

Jainco Projects (India)

₹6.97image

₹5.81 (0.20%)

HITECHCORP

Hitech Corporation

₹194.70image

₹162.25 (0.20%)

Top Losers

MEHAI

Mehai Technology

₹13.75image

₹135.15 (-0.90%)

TRESCON

Trescon

₹9.60image

₹12.00 (-0.20%)

SAGL

Shalimar Agencies

₹9.80image

₹93.55 (-0.90%)

SHANGAR

Shangar Decor

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited